- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The Russian invasion of Ukraine has had a profound impact on the global energy market. The over reliance of European nations on Russian fossil fuels has posed a significant challenge to supply security. Italy, as one of the largest importers of natural gas, sourced 40% of its gas from Russia until 2021. However, in 2022, […]
Thailand e-commerce payments to surge by 13.7% in 2024, forecasts GlobalData
The Thailand e-commerce market is growing at a fast pace and is expected to surge by 13.7% in 2024, driven by growing consumer preference for online shopping and strong internet penetration, reveals GlobalData, a leading data and analytics company. GlobalData’s E-Commerce Analytics reveals that Thailand e-commerce market registered a compound annual growth rate (CAGR) of […]
Trump 2.0 will focus on tax cuts, while Biden 2.0 to prioritize meeting first-term agenda, says GlobalData
In the most anticipated political event of the year, the US presidential elections will see two generally unpopular candidates, Joe Biden and Donald Trump, battle for America’s vote. Election coverage has largely focused on each candidate’s unfavorable traits and left little room to discuss the wider implications should they win. A second term for Biden […]
Roche’s Vabysmo further showcases stronghold across wAMD and DME spaces, says GlobalData
Roche has recently presented post-hoc analysis results of the TENAYA (NCT03823287) and LUCERNE (NCT03823300) trials of Vabysmo (faricimab), a VEGF and Ang2 inhibitor, at the Association for Research in Vision and Ophthalmology (ARVO) conference. The data not only showcases Vabysmo’s efficacy in wet age-related macular degeneration (wAMD) and diabetic macular edema (DME) but also the […]
BIOSECURE Act forces US pharma to reevaluate China manufacturing reliance, says GlobalData
As the BIOSECURE Act progresses through the US legislative process, the US pharmaceutical industry finds itself at a crossroads. With heavy reliance on Chinese contract manufacturers, US companies are reevaluating their partnerships amidst the proposed regulations aimed at safeguarding national security interests. While the Act remains a topic of debate, some anticipate potential onshoring benefits, […]
UAE general insurance industry to reach $12.4 billion by 2028, forecasts GlobalData
The United Arab Emirates (UAE) general insurance industry is set to grow at a compound annual growth rate (CAGR) of 4.7% from AED37.8 billion ($10.3 billion) in 2024 to AED45.5 billion ($12.4 billion) in 2028, in terms of gross written premiums (GWP), forecasts GlobalData, a leading data and analytics company. According to GlobalData’s Insurance Database, […]
Climate change to drive growth in multiple sclerosis market, says GlobalData
A June 2024 literature review, published in the Lancet Neurology, by Sisodya and colleagues revealed that climate change has the potential to intensify multiple sclerosis (MS) symptoms. The collated evidence aligns with GlobalData’s MS epidemiology and market forecast, which anticipates an uptick in the prevalence and disease severity of MS. The rise of a more […]
Moderna’s mRESVIA FDA approval paves way for mRNA vaccines across multiple indications, says GlobalData
Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received FDA approval for use in adults aged 60 years and older, marking the first time that an mRNA vaccine has been approved for a disease other than COVID-19. This approval represents a significant development in the field and will likely encourage the use of mRNA technology […]
LNG regasification projects will dominate upcoming midstream project starts in China during 2024–28, finds GlobalData
The LNG regasification segment is set to dominate upcoming oil and gas midstream projects in China, accounting for about 47% of the midstream projects starting between 2024 and 2028, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Asia-Pacific Oil and Gas Projects by Development Stage, Capacity, Capex, Contractor Details of All New […]
Biosimilar market poised for significant growth in the coming years, says GlobalData
The rise of biologics has revolutionized treatments for traditionally hard-to-treat diseases, leading to the growth of the biosimilar market. As more biologics lose patent protection, the influx of biosimilars is set to expand, offering cost-effective alternatives and significantly impacting their respective markets. This dynamic shift promises broader access to critical therapies, according to GlobalData, a […]
Biopharmaceutical industry remains mixed over EU reform proposals, finds GlobalData
Reforms to the European Union’s (EU) general pharmaceutical legislation emerge as one of the key policy developments affecting the operating environment for the pharma industry. In a survey, respondents’ opinions on the impact of EU reform proposals were mixed, with the percentage of participants expressing positive, negative, or neutral views remaining varied, according to GlobalData, […]
GlobalData unveils AI governance framework to help companies implement AI responsibly and safely
Artificial Intelligence (AI) risks can seriously tarnish a company’s reputation. Potential issues range from copyright infringement to data privacy breaches and the risk of actual physical harm. Increased use of AI will also reinforce and exacerbate many of the society’s biggest challenges, including bias, discrimination, misinformation, and other online harms. Hence, to help companies implement […]
Biopharmaceutical industry’s growth optimism surges but lags behind 2022 levels, says GlobalData
The biopharmaceutical industry is showcasing increasing optimism regarding its growth prospects over the next 12 months. While the upward trend is a positive sign, it remains below the levels of confidence seen in 2022, finds GlobalData, a leading data and analytics company. In a recent GlobalData’s survey*, “The State of the Biopharmaceutical Industry 2024 (mid-year […]
PROTACs oncology market to hit $3.7 billion by 2030 despite lack of approved therapies, says GlobalData
Proteolysis targeting chimeras (PROTACs) are a promising approach to cancer treatment, yet after over two decades of research, not a single PROTAC has gained FDA approval. PROTACs are novel bifunctional compounds that promote the degradation of a protein of interest (POI) by connecting a POI ligand to an E3 ubiquitin ligase (E3) ligand through a […]
Amylyx’s efforts to explore other indications for Relyvrio seem to be bearing fruit, says GlobalData
In March 2024, Amylyx Pharmaceuticals announced that Relyvrio, a neuroprotective agent, failed to achieve its primary efficacy endpoints in the global Phase III PHOENIX trial for amyotrophic lateral sclerosis (ALS). Relyvrio/Albrioza was first approved in the US and Canada in September 2022 for the treatment of ALS. However, following the monumental setback, on April 4, […]
Future business success hinges on sustainability and circular economy practices, says GlobalData
As public demand for climate action and resource conservation grows, businesses must pivot to sustainability to thrive. Embracing circular economy principles, such as reducing waste and extending product lifecycles, is crucial. As a result, future success hinges on adopting innovative technologies and sustainable practices, ensuring businesses remain efficient, compliant, and resilient in an evolving regulatory […]
ADHD market to decline by over $900 million in 7MM during 2022-32, forecasts GlobalData
The attention-deficit/hyperactivity disorder (ADHD) market across the seven major markets (7MM*) is forecast to decline at a negative compound annual growth rate (CAGR) of 0.8% from $11.9 billion in 2022 to $11.0 billion in 2032, driven by patent expiries, high generic uptake in the largest ADHD market, namely the US, and limited innovator entrants, according […]
Sweden card payments market to grow by 8.3% in 2024, forecasts GlobalData
The Sweden card payments market is forecast to grow 8.3% in 2024 to reach SEK1.5 trillion ($138.3 billion), supported by high consumer preference for electronic payments, according to GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that card payment value in the Sweden registered a growth of 11.7% in 2022, driven […]
Rapid digitalization of agriculture sector increasing cybersecurity risks, says GlobalData
The adoption of technologies like robotics, artificial intelligence (AI), and the Internet of Things (IoT) across the agriculture sector is helping tackle various challenges, including labor shortages and climate change. However, this digitalization also puts the sector at risk of cyberattacks, says GlobalData, a leading data and analytics company. GlobalData’s latest thematic intelligence report, “Cybersecurity […]
GlobalData highlights importance of CMV tests during National Congenital Cytomegalovirus Awareness Month
National Congenital Cytomegalovirus Awareness Month is observed in June every year to raise awareness over cytomegalovirus (CMV), a common virus that typically causes mild or asymptomatic infections in individuals with healthy immune systems. However, when it comes to congenital CMV, the virus can have severe consequences for newborns, including permanent hearing loss, neurodevelopmental delays, and […]